The Boston scorecard was a successor specification, not a replica of the sitting general counsel. Must-haves: FDA-adjacent product counsel in the last five years, a public-company reporting cadence already lived, and the ability to keep a commercial team moving while a quality event is open. Disqualifiers: anyone whose last move had been announced in the trade press before the offer, anyone who needed to bring a deputy on day one, anyone who had never sat with an audit committee. What the board would judge at month six was an earnings-cycle legal pack that did not surprise the chief financial officer, a product-counsel rhythm the quality function trusted, and no market story that the company had lost its general counsel. What it would not judge was whether the successor copied the predecessor's outside-counsel panel. Panels get rebuilt. Confidentiality does not.
Listed medtech legal departments on that kind of file typically run 8 to 20 lawyers. The general counsel sat over product, quality, commercial, privacy and the SEC calendar, including the Form 8-K a gap in the seat would have forced. That scope is not the scope of a first officer. The California company was a venture-backed SaaS business whose first draft asked for a listed-company general counsel who had built a department of twelve. The company needed one lawyer who still drafts. At Series B-C the median in-house bench is one lawyer. High-growth SaaS companies later run four to ten. This company was still at one.
The California rewrite is the other scorecard, and it should not be blended into the Boston one. Must-haves were commercial pace, privacy treated as part of the product, a board pack a director can read, and the discipline to do the work for 12-18 months before adding a second lawyer. Disqualifiers: anyone whose last three years had been management-only, anyone who had never closed a SaaS revenue contract, anyone who wanted to bring a four-person team on day one. The failed draft had also assumed a deputy, a contracts manager and a legal-operations hire in year one. None of those seats were funded. It was silent on board packs, financing documents, and the outside-counsel panel the hire would have to reshape. The record is the California first general counsel case study.
If the officer will also own compliance, borrow the test from the New York payments file rather than a personality brief. Dossiers on that chief compliance officer search were written against the Justice Department's Evaluation of Corporate Compliance Programs: whether the programme is well designed, applied in good faith, and working in practice. Examinations named, not "regulatory experience." That is a scorecard fact. It is not a reason to fold the compliance officer into the legal officer when the board needed them separate. The file is the New York payments case study.